Autres langues Coral Laboratories Limited

Actions

CORALAB6

INE683E01017

Produits pharmaceutiques

Marché Fermé - Bombay S.E. Autres places de cotation 12:02:24 07/08/2026			Varia. 5j.	Varia. 1 janv.
577,90 ^INR	+3,57%		+0,62%	+31,79%

30/05	Coral Laboratories Limited recommande le versement d'un dividende final pour l'exercice 2025-2026	CI
30/05	Coral Laboratories Limited publie ses résultats pour le quatrième trimestre clos le 31 mars 2026	CI

Autres langues

30/05	Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026
30/05	Coral Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
23/04	Coral Laboratories Limited Appoints Diwakar Unnikrishna Menon as Company Secretary and Compliance Officer, Effective April 30, 2026
24/03	Coral Laboratories Commissions Expanded Ointment Unit at Dehradun Plant; Shares Fall 3%
23/03	Coral Laboratories completes expansion of ointment unit
13/02	Coral Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
30/12	Coral Laboratories Limited Announces Resignation of Dhwani Desai as Company Secretary and Compliance Officer, Effective January 31, 2026
14/11	Coral Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
13/10/25	Global markets live: Blackstone, Pfizer, Tesla, Stellantis, AstraZeneca…
13/10/25	Coral Laboratories approves capacity expansion at Dehradun plant
13/10/25	Coral Laboratories proposed capacity addition for ointment manufacturing 360,000 kgs
13/10/25	Coral Laboratories Limited Announces Capacity Expansion At the Plant Located at Dehradun
13/08/25	Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
30/05/25	Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2024-2025
30/05/25	Coral Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025
13/02/25	Coral Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
14/08/24	Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
09/08/24	Coral Laboratories Limited Announces Cessation of Sheela Kamdar as Independent Director
13/07/24	Coral Laboratories Limited Proposes Final Dividend for Year Ended March 31, 2024
13/07/24	Coral Laboratories Limited Appoints Dhwani Desai as Company Secretary and Compliance Officer, Effective July 15, 2024
05/07/24	Coral Laboratories Board to Consider Final Dividend for Fiscal 2024
04/07/24	Coral Laboratories Limited Announces Resignation of Ruchi Pipara as Company Secretary and Compliance Officer, with Effect from July 13, 2024
23/05/24	Coral Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
23/05/24	Coral Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
24/04/24	Coral Laboratories Limited Appoints Ruchi Pipara as Company Secretary, Compliance Officer and Key Managerial Personnel